Sentence examples for molecular testing has from inspiring English sources
Molecular testing has shown the H5N2 virus is nearly identical to viruses isolated in migratory ducks, according to the USDA.
Molecular testing has become standard of care for the diagnostic workup of any suspected MPN, with JAK2 V617F being the most useful first test for polycythemia vera (PV), essential thrombocythemia (ET), and primary myelofibrosis (PMF).
The addition of HPV-surveillance by p16 staining and molecular testing has become commonplace in the work-up of these tumors, and cases of HPV-mediated disease are on the rise [9].
No molecular testing has been performed, and there is no familial history for long QT-syndrome.
Molecular testing has improved sensitivity over culture for detection of bacterial pathogens from pleural fluid[ 3].
Molecular testing has now disclosed a pathogenic mutation in nine of them.
New developments in the treatment and management of phenylketonuria (PKU) as well as advances in molecular testing have emerged since the National Institutes of Health 2000 PKU Consensus Statement was released.
Cytogenomic and molecular testing have helped to define the underlying genetic etiology for many of these syndromes and clarified why related genes in the same pathway sometimes lead to similar clinical phenotypes.
Our cohort of patients with diagnostic molecular testing had a high percentage of FLT3-ITD mutations (59%), and 73% were classified as intermediate-1 group by ELN (compared to approximately 30%and20%0% respectively in large analyses of unselected NK-AML patients).
Unlike many other forms of retinitis pigmentosa in which a large fraction of the photoreceptors have already been lost by the time a diagnosis is made, newborn hearing tests coupled with increasingly sensitive molecular testing have the potential to identify patients affected with Usher syndrome early enough that the majority of their photoreceptors are still amenable to gene replacement therapy.
We also found similar survival outcomes for patients transplanted before 2006 compared to the ELN not assigned patients transplanted after 2006, which suggests that the referral patterns for NK-AML without diagnostic molecular testing have not significantly evolved over the past decade.
